查和研究血液miRNAs作为皮质甲状腺癌的潜在诊断标记

Xize Li1, Wen Qin2, Wenting Wang1

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Jinan, 250012, People's Republic of China.

OncoTargets and therapy
|December 16, 2024
PubMed
概括

这项研究确定了针对乳头甲状腺癌 (PTC) 的新型基于血液的microRNA (miRNA) 生物标志物. miR-182-5p显示出作为诊断和预后指标的潜力,与PTC患者的不良结果相关.